Stay updated on GVAX & Pembrolizumab in MMR-p CRC Clinical Trial
Sign up to get notified when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.

Latest updates to the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA clarifying line about publications being provided voluntarily has been added to the Publications section, and a revision tag (v3.3.2) appears, while the previous wording for v3.2.0 was removed.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the government funding status notice banner from the page; this banner previously warned that information may not be up to date. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedThe updates appear to be cosmetic UI/layout changes with no modifications to study details, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

- Check69 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page version was updated from v3.0.1 to v3.0.2, and the Back to Top element was removed. No substantive changes to core content, pricing, stock, or time-slot information.SummaryDifference0.2%

Stay in the know with updates to GVAX & Pembrolizumab in MMR-p CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.